Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE : revenue, balance sheet and financial ratios

SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE is a French company founded 6 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in VALENCE (26000), this company of category PME shows in 2024 a net income positive of 26 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE (SIREN 878924281)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income 26 149 € -6 230 € -3 440 €
EBITDA -3 853 € -3 224 € -3 440 €
Net margin N/C N/C N/C

Revenue and income statement

In 2024, SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE generates positive net income of 26 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-3 853 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-3 853 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

26 149 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 85%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.9 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

85.251%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

53.981%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.874

Solvency indicators evolution
SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE

Sector positioning

Debt ratio
85.25 2024
2022
2023
2024
Q1: 0.01
Med: 13.69
Q3: 116.56
Average -8 pts over 3 years

In 2024, the debt ratio of SPFPL DE LA PHARMACIE DE ... (85.25) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
53.98% 2024
2022
2023
2024
Q1: 13.95%
Med: 55.8%
Q3: 90.35%
Average +20 pts over 3 years

In 2024, the financial autonomy of SPFPL DE LA PHARMACIE DE ... (54.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.87 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.15 years
Q3: 4.69 years
Average +29 pts over 3 years

In 2024, the repayment capacity of SPFPL DE LA PHARMACIE DE ... (0.87) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Positioning of SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (26 transactions). This range of 73 443€ to 506 730€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
73k€ 339k€ 506k€
339 355 € Range: 73 443€ - 506 730€
NAF 5 année 2024
How is this estimate calculated?

This estimate is based on the analysis of 26 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE with other companies in the same sector:

Frequently asked questions about SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE

What is the revenue of SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE ?

The revenue of SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE profitable?

Yes, SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE generated a net profit of 26 k€ in 2024.

Where is the headquarters of SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE ?

The headquarters of SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE is located in VALENCE (26000), in the department Drome.

Where to find the tax return of SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE ?

The tax return of SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE operate?

SPFPL DE LA PHARMACIE DE LA GRANDE ARCHE operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.